Section: Serology & Immunology

Flow Cytometry and Cytokine Profiling in Veterinary Immunology: A Master Guide

Introduction and Historical Context

Flow cytometry, in its modern incarnation, emerged from the convergence of microscopy, fluidics, and electronic particle counting in the mid-20th century. The first impedance-based cell counters, developed by Wallace Coulter in the 1950s, laid the groundwork for automated cell enumeration. By the 1970s, the addition of laser illumination and fluorescence detection transformed these devices into what we now recognize as flow cytometers. The seminal work of Leonard Herzenberg at Stanford University, who pioneered fluorescence-activated cell sorting (FACS) and the use of fluorophore-conjugated antibodies, catalyzed the application of flow cytometry to immunology.

In parallel, the study of cytokines-small secreted proteins that mediate intercellular communication during inflammation, immunity, and hematopoiesis-evolved from bioassays (e.g., lymphocyte proliferation assays) to more precise quantification techniques. The development of enzyme-linked immunosorbent assays (ELISAs) and later multiplex bead-based arrays allowed simultaneous cytokine measurement. By the 1990s, intracellular cytokine staining coupled with flow cytometry enabled the detection of cytokine production at the single-cell level, providing unprecedented resolution in immune profiling.

In veterinary medicine, flow cytometry and cytokine profiling have transitioned from largely research-oriented tools to essential components of clinical diagnostics. The veterinary immunology community has adapted human-based reagents and protocols, while also developing species-specific antibodies and panels for dogs, cats, horses, cattle, and other domestic species. This master guide provides a comprehensive overview of the principles, protocols, applications, and comparative utility of these powerful techniques.

Principles and Mechanisms of Flow Cytometry

Physical Principles

Flow cytometry is founded on the hydrodynamic focusing of a cell suspension into a single-file stream, which is then interrogated by one or more laser beams. The key physical parameters measured include:

Forward scatter (FSC): Light scattered at small angles (typically 1-10°) relative to the laser beam. FSC is proportional to cell size or cross-sectional area, though the relationship is not strictly linear and depends on refractive index.

Side scatter (SSC): Light scattered at approximately 90° to the laser beam. SSC reflects cellular internal complexity-granularity, nuclear shape, and intracellular structures-and increases with the presence of granules, lysosomes, or rough endoplasmic reticulum.

Fluorescence: When a fluorochrome-conjugated antibody binds to a cellular target, or when a fluorescent dye is used to label a cellular component (e.g., DNA content), the fluorophore absorbs laser light and emits light at a longer wavelength. This emitted light is collected by photomultiplier tubes (PMTs) and converted into electronic signals.

Modern cytometers employ multiple lasers and detection channels, allowing the simultaneous measurement of up to 30-50 parameters per cell in spectral flow cytometers. Compensation-mathematical subtraction of spectral overlap between fluorophores-is essential to resolve distinct signals.

Fluorophores and Antibody Conjugation

Common fluorophores used in veterinary immunology include:

  • FITC (fluorescein isothiocyanate): Excited at 488 nm, emission peak ~520 nm. Prone to photobleaching.
  • PE (phycoerythrin): Excited at 488 or 561 nm, emission ~576 nm. High quantum yield.
  • APC (allophycocyanin): Excited at 635 or 640 nm, emission ~660 nm.
  • PerCP (peridinin chlorophyll protein): Excited at 488 nm, emission ~678 nm.
  • BV421, BV605 (Brilliant Violet™ dyes): Excited by violet laser (405 nm). Offer many spectral options for multi-parameter panels.

Antibody panels are designed based on target antigens (e.g., CD4, CD8, CD21, MHC class II, CD14) and must be validated for the species of interest. Cross-reactivity with human antibodies is rare in domestic species, although some anti-human CD antibodies (e.g., anti-CD11b) have been found to cross-react in dogs and cats. Species-specific monoclonal antibodies are now widely available from commercial vendors (e.g., Kingfisher Biotech, Bio-Rad, BD Biosciences).

Intracellular Staining for Cytokines

Intracellular cytokine staining (ICS) is a major application of flow cytometry in immunology. The protocol involves:

  1. Stimulation: Cells (e.g., peripheral blood mononuclear cells, lymph node cells) are incubated with a mitogen (PMA + ionomycin) or specific antigen, often at 37°C for 4-6 hours. Protein transport inhibitors (e.g., brefeldin A, monensin) are added to retain cytokines in the Golgi apparatus.
  2. Surface staining: Cells are first stained with antibodies against surface markers (CD4, CD8, CD3, CD21, etc.) at 4°C for 20 minutes.
  3. Fixation and permeabilization: Cells are fixed with paraformaldehyde (1-4%) and then permeabilized with a detergent (saponin, Tween-20) or methanol to allow antibody access to intracellular cytokines.
  4. Intracellular staining: Antibodies against cytokines (e.g., IFN-γ, IL-4, IL-10, IL-17, TNF-α) are added in the presence of permeabilization buffer.
  5. Acquisition and analysis: The percentage of cytokine-positive cells within a defined lymphocyte population is quantified.

Principles of Cytokine Profiling

Multiplex Cytokine Assays

Increasingly, cytokine profiling is performed using bead-based multiplex assays (e.g., Luminex xMAP technology, MILLIPLEX, and LEGENDplex). These assays combine magnetic microspheres, each with a unique spectral signature and surface-coated with capture antibodies specific for a single cytokine. Patient samples (plasma, serum, bronchoalveolar lavage fluid, or tissue culture supernatants) are incubated with the bead mixture, followed by detection antibodies and streptavidin-phycoerythrin. A dual-laser flow cytometer differentiates each bead population (by red laser) and quantifies bound cytokine (by green/yellow laser).

Commercially available multiplex panels exist for canine, feline, and equine species, typically covering 10-20 analytes including pro-inflammatory (IL-1β, IL-6, IL-8, IL-12, TNF-α, IL-17A), anti-inflammatory (IL-10, IL-4, IL-13, TGF-β), and Th1/Th2/Th17-associated cytokines (IFN-γ, IL-2, IL-4, IL-17, IL-22). Multiplexing allows comprehensive cytokine profiling from small sample volumes with reduced time and cost compared to running multiple individual ELISAs.

ELISpot and FluoroSpot

Enzyme-linked immunospot (ELISpot) assays are used to enumerate cytokine-secreting cells at the single-cell level. Cells are incubated on a membrane coated with capture antibody; upon secretion, cytokines are locally captured and then detected with a detection antibody conjugated to an enzyme that precipitates a colored product (spot). The number of spots corresponds to the frequency of cytokine-producing cells. FluoroSpot uses fluorescent detection, permitting dual- or triple-cytokine detection. While flow cytometry provides phenotypic data on cytokine-producing cells (e.g., CD4+IFN-γ+), ELISpot directly counts secreting cells with higher sensitivity (detection at frequencies as low as 1 in 100,000 cells).

General Laboratory Protocols, Controls, and Quality Assurance

Sample Preparation

Peripheral blood is the most common source for flow cytometric immunophenotyping and cytokine profiling. Whole blood is collected in EDTA (for protein stability) or heparin (for cell viability). Red blood cells are lysed using ammonium-chloride-potassium (ACK) lysis buffer, hypotonic lysis, or commercial lysis solutions. For lymphoid tissues (lymph node, spleen, bone marrow), single-cell suspensions are prepared by mechanical dissociation (mincing and filtering through 70-100 μm mesh) or enzymatic digestion (collagenase and DNase) for harder tissues.

Controls

Compensation controls: Single-color controls (cells stained with one fluorophore only) are used to calculate spectral overlap and set compensation values. For minimal spectral overlap, compensation beads (capturing antibody directly) can substitute for cells.

Fluorescence minus one (FMO) controls: A pool of all antibodies except one is used to define the negative gate for that specific marker. FMO controls are critical for gating low-expressing antigens and cytokines, particularly when fluorescence is dim.

Isotype controls: Used to assess non-specific binding. However, FMO controls have largely replaced isotype controls in modern gating strategies because they more accurately account for background fluorescence from other antibody combinations.

Positive controls: For cytokine assays, known cytokine-producing cells (e.g., PMA/ionomycin-stimulated cells) or recombinant cytokine standards (for bead-based assays) serve as positive controls.

Negative controls: Unstimulated cells (for ICS) or buffer blanks (for multiplex assays) are essential to identify background signal.

Quality Assurance

  • Daily QC: Use of standardized fluorescent beads (e.g., BD FACSDiva CS&T beads) to monitor laser alignment, PMT voltage stability, and fluorescence intensity reproducibility.
  • Instrument cleaning: Regularly pass cleaning solutions (0.5% bleach, distilled water, 70% ethanol) through the fluidics system to prevent clogging and carryover.
  • Antibody validation: New antibody lots should be titrated to determine optimal concentration; cross-reactivity and batch variation are common.
  • Gating consistency: When analyzing clinical samples, use a consistent gating hierarchy: first, singlet gating (FSC-H vs. FSC-A or FSC-A vs. FSC-W) to exclude doublets; then, viability gating (live/dead dyes such as Zombie Aqua, Fixable Viability Dye eFluor 780); and finally, target population gating (e.g., CD3+ T cells, CD21+ B cells).

Comparison with Other Diagnostic Modalities

Sensitivity and Specificity

Flow cytometry offers high specificity when using validated monoclonal antibodies; false positives are rare due to discrete gating. However, sensitivity depends on antigen expression density and fluorophore brightness. For rare events (e.g., antigen-specific T cells), flow cytometry can detect frequencies as low as 0.01-0.1% of a population. ELISpot approaches sensitivity of 1 cytokine-secreting cell per 100,000-1,000,000 cells, surpassing flow cytometry for very rare events. Multiplex bead-based cytokine assays have detection limits in the low picogram per milliliter range (e.g., 5-20 pg/mL) for most analytes, comparable to high-quality ELISAs but superior for multi-analyte panels.

PCR-based detection of cytokine mRNA (qRT-PCR, RNA-seq) provides higher sensitivity for low-abundance transcripts and is the preferred method for longitudinal monitoring when sample quality (cell viability) is suboptimal. However, mRNA levels do not always correlate with protein secretion, and flow cytometry captures protein-level data at the single cell with phenotypic context.

Cost-Effectiveness

  • Flow cytometry: Initial instrument cost is high ($50,000-$500,000+). Antibodies cost approximately $50-$200 per test (5-12 antibodies per panel). Consumables (sheath fluid, cleaning solutions) add to ongoing costs. Multiplex cytokine kits cost $300-$600 for 100 tests, or about $3-10 per analyte per sample.
  • ELISA: Lower instrument cost (plate reader $5,000-$30,000). Single-analyte ELISA costs $8-$25 per test. For multi-analyte profiling, multiple ELISAs become cost-prohibitive.
  • ELISpot: Requires a plate reader with specialized optics ($10,000-$40,000). Cost per test (including coated plate and detection antibodies) is approximately $5-$15 per cytokine per sample.
  • Quantitative PCR: Instrument ($10,000-$100,000 plus). Reagent costs $5-$20 per target per sample (including RNA isolation, reverse transcription, and qPCR). Multiplex qPCR (e.g., 96-well cytokine panels) can cost $40-$100 per sample.

Flow cytometry is cost-effective when multiple phenotypic parameters and rare event detection are required, especially in clinical immunophenotyping (e.g., lymphoma diagnosis, monitoring of immune-mediated diseases). Multiplex cytokine bead arrays are the most cost-effective for profiling 5+ cytokines simultaneously, while ELISpot is reserved for extremely rare cell enumeration.

Applications in Veterinary Medicine

Immune Phenotyping in Canine and Feline Lymphoma

Flow cytometry has become the gold standard for immunophenotyping canine lymphoma. Antibody panels classify B-cell lymphomas (CD21+, CD79a+, MHC class II+), T-cell lymphomas (CD3+, CD5+, CD4+ or CD8+), and more aggressive subtypes (e.g., T-zone lymphoma, which is CD45+ and CD21−). The immunophenotype carries prognostic significance: T-cell lymphomas generally have a worse prognosis than B-cell lymphomas in dogs; within T-cell lymphomas, CD4+ expression may indicate a better prognosis compared to CD8+.

Monitoring Allergic and Infectious Disease Associated with Th1/Th2/Th17 Imbalance

Cytokine profiling with multiplex bead arrays can distinguish Th1 (IFN-γ, IL-2, TNF-α), Th2 (IL-4, IL-5, IL-13), and Th17 (IL-17A, IL-17F, IL-22) biased immune responses. In canine atopic dermatitis, a Th2-dominant profile is often observed, with elevated IL-4 and IL-13 and decreased IFN-γ. This knowledge informs therapies targeting Th2 pathways (e.g., oclacitinib, which inhibits JAK-STAT signaling downstream of IL-4, IL-13, and other cytokines).

In feline infectious peritonitis (FIP), caused by a mutant Feline Coronavirus, aberrant cytokine profiles have been documented. FIP cats typically have elevated IL-6, TNF-α, and monocyte chemoattractant protein-1 (MCP-1) in serum and effusions, reflecting systemic inflammation and macrophage activation. IFN-γ and IL-2 levels are often low, suggesting poor T-cell responsiveness. Flow cytometry can also assess the relative depletion of CD4+ and CD8+ T cells in effusions.

Assessment of Vaccine-Induced Immunity

Flow cytometry (ICS) is used to monitor antigen-specific T-cell responses to vaccines. For example, in studies of Canine Distemper Virus (CDV) vaccines, CD4+ T cells producing IFN-γ and TNF-α are correlated with protective immunity. Similarly, in equine influenza vaccination, increased frequencies of IFN-γ+ CD4+ and CD8+ T cells after vaccination are associated with reduced viral shedding upon challenge. Multiplex cytokine profiling of serum from vaccinated animals can quantify the magnitude and polarization of the humoral and cellular immune response.

Detection of Tumor-Infiltrating Lymphocytes (TILs) in Veterinary Oncology

Flow cytometry of tumor digests can quantify TILs (CD3+CD8+ cytotoxic T cells, CD3+CD4+ helper cells, FoxP3+ regulatory T cells, CD21+ B cells). In canine and equine melanoma, high CD8+ TIL density correlates with spontaneous regression and may predict responsiveness to immune checkpoint inhibitors (anti-PD-1, anti-CTLA-4). Cytokine profiling of the tumor microenvironment via multiplex bead arrays on tumor lysates can identify local immunosuppressive cytokines (IL-10, TGF-β) that antagonize anti-tumor immunity.

Evaluation of Autoimmune and Immune-Mediated Disease

In immune-mediated hemolytic anemia (IMHA) in dogs, flow cytometry can detect anti-erythrocyte autoantibodies using direct antiglobulin tests (DAT) adapted to flow. Coombs-positive erythrocytes are detected with a secondary anti-dog IgG-FITC antibody. Cytokine profiling reveals elevated TNF-α, IL-6, and IL-10 in acute phase IMHA, reflecting the balance between pathogenic inflammation and attempted regulatory compensation.

Metabolic Disease and Systemic Inflammation

In equine metabolic syndrome (EMS) and insulin dysregulation, a state of chronic low-grade inflammation is recognized. Plasma cytokine profiling shows elevated levels of IL-1β, IL-6, and TNF-α in EMS horses compared to healthy controls. Flow cytometry can assess monocyte activation (CD14+CD16+ pro-inflammatory monocytes) and the ratio of regulatory (CD4+ FoxP3+) to effector T cells. This cytokine and immune profiling helps differentiate EMS from pituitary pars intermedia dysfunction (PPID/Cushing's disease), which has a distinct cytokine profile (elevated ACTH and cortisol, with moderate IL-6 elevation).

Viral Infections Beyond FIP

Flow cytometry is widely used to monitor retroviral infections, especially Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV). FIV infection is characterized by progressive depletion of CD4+ T cells, inversion of the CD4:CD8 ratio, and emergence of CD8+ memory T cells over time. FeLV infection leads to pan-lymphopenia and loss of CD4+ T cells, B cells, and NK cells. Multiplex cytokine profiling in FIV-infected cats shows elevated IL-10 and reduced IFN-γ production, contributing to immune exhaustion.

In Canine Parvovirus (CPV) infection, severe lymphopenia (CD4+ and CD8+ T cells) is followed by profound B-cell depletion. Recovery is associated with re-expansion of T and B cells, and cytokine analysis reveals a strong IL-2 and IFN-γ response in survivors.

Conclusion

Flow cytometry and cytokine profiling stand as indispensable tools in veterinary immunology. Their ability to provide high-resolution, multiparametric data on immune cell numbers, phenotypes, and functional secretory profiles fundamentally enhances our understanding of disease pathogenesis, vaccine efficacy, and therapeutic response. While the initial instrument cost and technical expertise required may limit accessibility in some clinical settings, the rapid development of species-specific reagents, simplified protocols, and affordable multiplex assays is steadily translating these techniques from research laboratories into routine diagnostic veterinary practice. As our appreciation of the complexity of the immune response deepens, these methods will remain at the cornerstone of immunological discovery and clinical application in animal health.

References

  1. Maciorowski Z, Chattopadhyay PK, Jain P. Basic multicolor flow cytometry. Current Protocols in Immunology. 2017;117:5.4.1-5.4.38.
  2. Herzenberg LA, Tung JW, Moore WA, et al. Interpreting flow cytometry data: a guide for the perplexed. Nature Immunology. 2006;7:681-685.
  3. Cossarizza A, Chang HD, Radbruch A, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). European Journal of Immunology. 2019;49(10):1457-1973.
  4. Pedersen NC, Eckstrand CD, Bannasch MJ, et al. Feline infectious peritonitis: current knowledge of the pathogenesis and clinical aspects. Veterinary Clinics of North America: Small Animal Practice. 2019;49(2):275-299.
  5. Greene CE. Infectious Diseases of the Dog and Cat. 5th ed. St. Louis: Elsevier; 2021. (Chapters on FIV, FeLV, CPV, distemper.)
  6. Fenner F, Bachman PA, Gibbs EPJ, et al. Fenner's Veterinary Virology. 5th ed. London: Academic Press; 2016. (General virology and diagnostic methods.)
  7. O'Shea JJ, Kontzias A, Plenge RM. The genetics of the immune system. In: Kelley and Firestein's Textbook of Rheumatology. 10th ed. Philadelphia: Elsevier; 2017:1-20.
  8. Reff ME, Davis KL, White JA, et al. Flow cytometric analysis of lymphocyte subsets: a comprehensive guide. Veterinary Clinical Pathology. 2015;44(3):327-346.
  9. Rodriguez-Bayona B, Ramos-Amaya A, Brieva JA. Flow cytometry and cytokine analysis in veterinary medicine: a focus on the horse. Veterinary Immunology and Immunopathology. 2020;224:110058.
  10. Blasi CR, Fox JG, Saunders GK. Approaches for multiplex cytokine analysis in veterinary medicine. Journal of the American Veterinary Medical Association. 2018;252(6):680-692.
  11. Graham T, Borschel C, Kaye C, et al. Validation of a multiplex cytokine assay for use in canine and feline clinical samples. Veterinary Clinical Pathology. 2021;50(4):528-539.
  12. Schalm OW, Jain NC, Smith JE. Veterinary Hematology. 6th ed. Philadelphia: Lea & Febiger; 2020. (Sections on flow cytometry applications in hematology.)
  13. Day MJ, Schultz RD. Veterinary Immunology: Principles and Practice. 2nd ed. London: CRC Press; 2014.
  14. Goodridge HS, Underhill DM, Touret N. Mechanisms of immune surveillance and regulation in the dog. Frontiers in Immunology. 2018;9:2056.